title: Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model.
abstract: Removing the spleen prior to ischemic stroke abrogates immunologic response to brain injury and reduces cerebral infarction. However, the effectiveness of splenectomy for neuroprotection after stroke has not been established. Moreover, the risks of the surgical splenectomy in stroke patients create a major obstacle to removing the spleen's inflammatory response. We hypothesized that acute splenic irradiation will ablate splenic cells and thereby will diminish stroke progression. Male adult Sprague Dawley rats were subjected to 2-hour middle cerebral artery occlusion (MCAO), then CT scanned for spleen localization and irradiated to the lateral splenic region with 8Gy of Cobalt 60 at 3, 4, 6 or 8 hrs after start of cerebral ischemia. Untreated controls underwent the same procedures except that sham irradiation was applied. At 2 or 7 days after ischemia the rats were euthanized, and brains recovered for the assessment of brain injury and the extent of neuroinflammation. Irradiation at 3 hrs reduced spleen weight and lymphocyte blood levels after stroke. Splenic irradiation at 3 and 4 hrs after start of ischemia significantly reduced cerebral infarction volumes measured at 48 hrs and 7 days, respectively. The histological analysis on day 7 revealed reduced counts of microglia, infiltrating T cells, and apoptotic neurons in the rats irradiated at 4 hrs. The noninvasive single-dose procedure of splenic irradiation performed within a time interval of up to 4 hours offers neuroprotection against ischemic stroke possibly by abrogating deployment of splenic cells to the brain.
authors: Departments of Physiology and Pharmacology (R.P.O., A.M., J.H.Z.), Radiation Medicine (R.S.W., Y.N., T.L., T.L., D.S.G.), Neurosurgery (J.H.Z.) and Anesthesiology (J.H.Z.), Loma Linda University, Loma Linda, CA, USA and the Department of Experimental and Clinical Neuropathology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland (R.P.O.).
authors: Robert P
authors: RP
authors: Ostrowski
authors: Reinhard W
authors: RW
authors: Schulte
authors: Ying
authors: Y
authors: Nie
authors: Ted
authors: T
authors: Ling
authors: Timothy
authors: T
authors: Lee
authors: Anatol
authors: A
authors: Manaenko
authors: Daila S
authors: DS
authors: Gridley
authors: John H
authors: JH
authors: Zhang
keywords: Cobalt-60; cerebral ischemia; lymphocyte; neuroinflammation; rats; spleen
references: Exp Toxicol Pathol. 2006 Jan;57(3):213-9
references: 16343876
references: J Neurol Sci. 2011 Jul 15;306(1-2):143-53
references: 21481895
references: J Mol Neurosci. 2009 Jun;38(2):220-6
references: 19051061
references: J Cereb Blood Flow Metab. 2007 Nov;27(11):1798-805
references: 17392692
references: Strahlenther Onkol. 2001 Feb;177(2):105-11
references: 11233832
references: Onkologie. 2003 Feb;26(1):21-4
references: 12624513
references: Radiat Oncol. 2006 Sep 06;1:35
references: 16956411
references: Transl Stroke Res. 2011 Sep;2(3):328-38
references: 24323652
references: Undersea Hyperb Med. 1999 Summer;26(2):111-22
references: 10372431
references: Stroke. 2010 Feb;41(2):368-74
references: 19940275
references: J Exp Med. 2003 Sep 1;198(5):725-36
references: 12939340
references: Stroke. 1995 Apr;26(4):627-34; discussion 635
references: 7709410
references: J Immunol. 2003 Jul 1;171(1):368-79
references: 12817020
references: Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):141-4
references: 7954049
references: Neurochem Int. 1997 Apr-May;30(4-5):427-31
references: 9106257
references: Int Rev Cytol. 1992;132:31-74
references: 1555921
references: Prog Neurobiol. 2004 Feb;72(2):111-27
references: 15063528
references: J Neurosci Res. 2008 Aug 1;86(10):2227-34
references: 18381759
references: Stroke. 2011 Feb;42(2):484-90
references: 21164135
references: Stroke. 2009 May;40(5):e331-9
references: 19182083